Subscribe
shutterstock_1650524983_sundry_photography
Sundry Photography / Shutterstock.com
13 August 2020AmericasRory O'Neill

BGI wins partial lifting of Illumina injunction

Beijing-based  BGI Genomics can continue to develop its DNA sequencing technology pending an appeal in a patent dispute with  Illumina, a US federal court has ruled.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Illumina secures injunction against BGI
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Americas
Illumina to acquire Jeff Bezos-backed cancer testing company
23 September 2020   Genetic sequencing company Illumina is set to pay $8 billion for Grail, a cancer detection company that was spun out of Illumina four years ago.
Big Pharma
Illumina prevails against BGI at English High Court
21 January 2021   Illumina has secured a victory in its patent dispute with Chinese genome sequencing company BGI at the English High Court, which ruled that four of its patents had been infringed.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
Illumina secures injunction against BGI
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Americas
Illumina to acquire Jeff Bezos-backed cancer testing company
23 September 2020   Genetic sequencing company Illumina is set to pay $8 billion for Grail, a cancer detection company that was spun out of Illumina four years ago.
Big Pharma
Illumina prevails against BGI at English High Court
21 January 2021   Illumina has secured a victory in its patent dispute with Chinese genome sequencing company BGI at the English High Court, which ruled that four of its patents had been infringed.

More on this story

Americas
Illumina secures injunction against BGI
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Americas
Illumina to acquire Jeff Bezos-backed cancer testing company
23 September 2020   Genetic sequencing company Illumina is set to pay $8 billion for Grail, a cancer detection company that was spun out of Illumina four years ago.
Big Pharma
Illumina prevails against BGI at English High Court
21 January 2021   Illumina has secured a victory in its patent dispute with Chinese genome sequencing company BGI at the English High Court, which ruled that four of its patents had been infringed.

More features

Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court